The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The RNA Analysis/ Transcriptomics Market Projected To Become By 2030 Based On Its 2026 Valuation?
The market size for rna analysis/ transcriptomics has experienced swift expansion recently. This market is projected to expand from $8.74 billion in 2025 to $10.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.9%. Historically, this growth can be ascribed to several factors, including the broadening of genomic research initiatives, the increased uptake of rna sequencing technologies, an uplift in funding for life sciences research, the accessibility of sophisticated laboratory tools, and heightened academic research endeavors.
The rna analysis/ transcriptomics market size is expected to experience significant growth in the coming years. It is projected to reach $19.04 billion in 2030, showing a compound annual growth rate (CAGR) of 16.8%. The expansion during the forecast period can be attributed to factors such as increasing demand for precision medicine applications, the rising use of transcriptomics in drug discovery, the broadening of clinical diagnostics based on gene expression, growing investments in bioinformatics infrastructure, and an increasing focus on personalized therapeutics. Key trends for the forecast period include the increasing adoption of next-generation sequencing platforms, the rising application of high-throughput transcriptomic profiling, the growing integration of advanced bioinformatics tools, the expansion of single-cell rna analysis techniques, and an enhanced focus on reproducibility and data accuracy.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5241&type=smp
Which Market Drivers Are Supporting The Expansion Of The RNA Analysis/ Transcriptomics Market?
The anticipated expansion of the RNA analysis/ transcriptomics market is linked to the growing occurrence of chronic diseases. These conditions are defined as illnesses persisting for at least a year, hindering daily routines, demanding ongoing medical attention, or a combination thereof. The surge in chronic disease cases primarily stems from increasingly inactive lifestyles, which compromise metabolic health due to reduced daily physical activity, thereby increasing the risk of long-term ailments. RNA analysis/transcriptomics contributes to managing chronic diseases by identifying gene activity alterations that drive the conditions, facilitating earlier identification, more precise diagnoses, and the creation of targeted, individualized therapies. As an illustration, the National Health Service, a UK-based government department, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) had received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar not yet reaching diabetic levels) in 2023. This figure represented an 18% increase from 3,065,825 cases recorded in 2022. Consequently, the rising incidence of chronic illnesses is propelling the growth of the RNA analysis/ transcriptomics market.
What Segment Groups Are Identified Within The RNA Analysis/ Transcriptomics Market?
The rna analysis/ transcriptomics market covered in this report is segmented –
1) By Product: Reagents/Consumables, Instruments, Software
2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction
3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference
Subsegments:
1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits
2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers
3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems
What Trends Are Advancing Progress In The RNA Analysis/ Transcriptomics Market?
Leading companies active in the RNA analysis/transcriptomics market are intensifying their efforts to launch innovative portfolios, aiming to gain a market advantage. The RNA Portfolio involves developing new technologies and solutions engineered to boost the efficiency and efficacy of RNA analysis. For example, in May 2023, Twist Bioscience Corporation, a US-based biotechnology entity, revealed the debut of a collection of RNA sequencing tools. This collection includes specific target enrichment functionalities for RNA and whole transcriptome sequencing, as well as the Twist RNA Exome, the Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit. The offerings within this portfolio provide full workflows for analyzing messenger RNA (mRNA) protein coding sequences, custom targets, and total RNA, all with the goal of measuring the transcriptome. Moreover, these products can be seamlessly incorporated into their clients’ current workflows.
Which Companies Hold Significant Positions In The RNA Analysis/ Transcriptomics Market?
Major companies operating in the rna analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.
Read the full rna analysis/ transcriptomics market report here:
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
How Is The RNA Analysis/ Transcriptomics Market Distributed Across Key Geographic Regions?
North America was the largest region in the RNA analysis/transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna analysis/ transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored RNA Analysis/ Transcriptomics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=5241&type=smp
Browse Through More Reports Similar to the Global RNA Analysis/ Transcriptomics Market 2026, By The Business Research Company
Rna Sequencing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report
Ngs Based Rna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Ribonucleic Acid Rna Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model